Electrophysiology Devices Market (Product Type: Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Fo

Electrophysiology Devices Market (Product Type: Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Companies Mentioned

Microport Scientific Corporation
Biotronik SE & Co.KG
Koninklijke Philips N.V.
Medtronic plc
GE Healthcare
Boston Scientific Corporation
Biosense Webster, Inc.
Nihon Kohden Corporation
F. Siemens AG
Acutus Medical, Inc.
Abbott Laboratories
Other Players

Countries

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Forecast Year (first) - 2022

Forecast Year (last) - 2031

Forecast Year ( first)  Value - 6.7

Forecast Year (last) Value - 14.8

CAGR % - 0.082

Currency - US$ Bn


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Electrophysiology Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Electrophysiology Devices Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Technological advancements
5.2. Key Industry Events
5.3. COVID-19 Impact
6. Global Electrophysiology Devices Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Electrophysiology Ablation Catheters
6.3.1.1. Cryoablation Electrophysiology Catheters
6.3.1.2. Radiofrequency Ablation Catheters
6.3.1.2.1. Irrigated-tip Radiofrequency Ablation Catheters
6.3.1.2.2. Conventional Radiofrequency Ablation Catheters
6.3.1.3. Laser Ablation Systems
6.3.1.4. Microwave Ablation Systems
6.3.1.5. Navigational Advanced Mapping Accessories
6.3.2. Electrophysiology Diagnostic Catheters
6.3.2.1. Conventional Electrophysiology Diagnostic Catheters
6.3.2.1.1. Steerable Diagnostic Catheters
6.3.2.1.2. Fixed Diagnostic Catheters
6.3.2.2. Advanced Electrophysiology Diagnostic Catheters
6.3.2.3. Ultrasound Electrophysiology Diagnostic Catheters
6.3.3. Electrophysiology Laboratory Devices
6.3.4. Access Devices
6.3.5. Others
6.4. Market Attractiveness Analysis, by Product Type
7. Global Electrophysiology Devices Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017–2031
7.3.1. Hospitals
7.3.2. Diagnostic Centers
7.3.3. Clinics
7.3.4. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Electrophysiology Devices Market Analysis and Forecast, by Indication
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Indication, 2017–2031
8.3.1. Atrial Fibrillation (AF)
8.3.2. Atrioventricular Nodal Reentry Tachycardia (AVNRT)
8.3.3. Wolff-Parkinson-White Syndrome (WPW)
8.3.4. Atrial Flutter
8.3.5. Others
8.4. Market Attractiveness Analysis, by Indication
9. Global Electrophysiology Devices Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Electrophysiology Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Electrophysiology Ablation Catheters
10.2.1.1. Cryoablation Electrophysiology Catheters
10.2.1.2. Radiofrequency Ablation Catheters
10.2.1.2.1. Irrigated-tip Radiofrequency Ablation Catheters
10.2.1.2.2. Conventional Radiofrequency Ablation Catheters
10.2.1.3. Laser Ablation Systems
10.2.1.4. Microwave Ablation Systems
10.2.1.5. Navigational Advanced Mapping Accessories
10.2.2. Electrophysiology Diagnostic Catheters
10.2.2.1. Conventional Electrophysiology Diagnostic Catheters
10.2.2.1.1. Steerable Diagnostic Catheters
10.2.2.1.2. Fixed Diagnostic Catheters
10.2.2.2. Advanced Electrophysiology Diagnostic Catheters
10.2.2.3. Ultrasound Electrophysiology Diagnostic Catheters
10.2.3. Electrophysiology Laboratory Devices
10.2.4. Access Devices
10.2.5. Others
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Hospitals
10.3.2. Diagnostic Centers
10.3.3. Clinics
10.3.4. Others
10.4. Market Value Forecast, by Indication, 2017–2031
10.4.1. Atrial Fibrillation (AF)
10.4.2. Atrioventricular Nodal Reentry Tachycardia (AVNRT)
10.4.3. Wolff-Parkinson-White Syndrome (WPW)
10.4.4. Atrial Flutter
10.4.5. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By End-user
10.6.3. By Indication
10.6.4. By Country
11. Europe Electrophysiology Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Electrophysiology Ablation Catheters
11.2.1.1. Cryoablation Electrophysiology Catheters
11.2.1.2. Radiofrequency Ablation Catheters
11.2.1.2.1. Irrigated-tip Radiofrequency Ablation Catheters
11.2.1.2.2. Conventional Radiofrequency Ablation Catheters
11.2.1.3. Laser Ablation Systems
11.2.1.4. Microwave Ablation Systems
11.2.1.5. Navigational Advanced Mapping Accessories
11.2.2. Electrophysiology Diagnostic Catheters
11.2.2.1. Conventional Electrophysiology Diagnostic Catheters
11.2.2.1.1. Steerable Diagnostic Catheters
11.2.2.1.2. Fixed Diagnostic Catheters
11.2.2.2. Advanced Electrophysiology Diagnostic Catheters
11.2.2.3. Ultrasound Electrophysiology Diagnostic Catheters
11.2.3. Electrophysiology Laboratory Devices
11.2.4. Access Devices
11.2.5. Others
11.3. Market Value Forecast, by End-user, 2017–2031
11.3.1. Hospitals
11.3.2. Diagnostic Centers
11.3.3. Clinics
11.3.4. Others
11.4. Market Value Forecast, by Indication, 2017–2031
11.4.1. Atrial Fibrillation (AF)
11.4.2. Atrioventricular Nodal Reentry Tachycardia (AVNRT)
11.4.3. Wolff-Parkinson-White Syndrome (WPW)
11.4.4. Atrial Flutter
11.4.5. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By End-user
11.6.3. By Indication
11.6.4. By Country/Sub-region
12. Asia Pacific Electrophysiology Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Electrophysiology Ablation Catheters
12.2.1.1. Cryoablation Electrophysiology Catheters
12.2.1.2. Radiofrequency Ablation Catheters
12.2.1.2.1. Irrigated-tip Radiofrequency Ablation Catheters
12.2.1.2.2. Conventional Radiofrequency Ablation Catheters
12.2.1.3. Laser Ablation Systems
12.2.1.4. Microwave Ablation Systems
12.2.1.5. Navigational Advanced Mapping Accessories
12.2.2. Electrophysiology Diagnostic Catheters
12.2.2.1. Conventional Electrophysiology Diagnostic Catheters
12.2.2.1.1. Steerable Diagnostic Catheters
12.2.2.1.2. Fixed Diagnostic Catheters
12.2.2.2. Advanced Electrophysiology Diagnostic Catheters
12.2.2.3. Ultrasound Electrophysiology Diagnostic Catheters
12.2.3. Electrophysiology Laboratory Devices
12.2.4. Access Devices
12.2.5. Others
12.3. Market Value Forecast, by End-user, 2017–2031
12.3.1. Hospitals
12.3.2. Diagnostic Centers
12.3.3. Clinics
12.3.4. Others
12.4. Market Value Forecast, by Indication, 2017–2031
12.4.1. Atrial Fibrillation (AF)
12.4.2. Atrioventricular Nodal Reentry Tachycardia (AVNRT)
12.4.3. Wolff-Parkinson-White Syndrome (WPW)
12.4.4. Atrial Flutter
12.4.5. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By End-user
12.6.3. By Indication
12.6.4. By Country/Sub-region
13. Latin America Electrophysiology Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Electrophysiology Ablation Catheters
13.2.1.1. Cryoablation Electrophysiology Catheters
13.2.1.2. Radiofrequency Ablation Catheters
13.2.1.2.1. Irrigated-tip Radiofrequency Ablation Catheters
13.2.1.2.2. Conventional Radiofrequency Ablation Catheters
13.2.1.3. Laser Ablation Systems
13.2.1.4. Microwave Ablation Systems
13.2.1.5. Navigational Advanced Mapping Accessories
13.2.2. Electrophysiology Diagnostic Catheters
13.2.2.1. Conventional Electrophysiology Diagnostic Catheters
13.2.2.1.1. Steerable Diagnostic Catheters
13.2.2.1.2. Fixed Diagnostic Catheters
13.2.2.2. Advanced Electrophysiology Diagnostic Catheters
13.2.2.3. Ultrasound Electrophysiology Diagnostic Catheters
13.2.3. Electrophysiology Laboratory Devices
13.2.4. Access Devices
13.2.5. Others
13.3. Market Value Forecast, by End-user, 2017–2031
13.3.1. Hospitals
13.3.2. Diagnostic Centers
13.3.3. Clinics
13.3.4. Others
13.4. Market Value Forecast, by Indication, 2017–2031
13.4.1. Atrial Fibrillation (AF)
13.4.2. Atrioventricular Nodal Reentry Tachycardia (AVNRT)
13.4.3. Wolff-Parkinson-White Syndrome (WPW)
13.4.4. Atrial Flutter
13.4.5. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By End-user
13.6.3. By Indication
13.6.4. By Country/Sub-region
14. Middle East & Africa Electrophysiology Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Electrophysiology Ablation Catheters
14.2.1.1. Cryoablation Electrophysiology Catheters
14.2.1.2. Radiofrequency Ablation Catheters
14.2.1.2.1. Irrigated-tip Radiofrequency Ablation Catheters
14.2.1.2.2. Conventional Radiofrequency Ablation Catheters
14.2.1.3. Laser Ablation Systems
14.2.1.4. Microwave Ablation Systems
14.2.1.5. Navigational Advanced Mapping Accessories
14.2.2. Electrophysiology Diagnostic Catheters
14.2.2.1. Conventional Electrophysiology Diagnostic Catheters
14.2.2.1.1. Steerable Diagnostic Catheters
14.2.2.1.2. Fixed Diagnostic Catheters
14.2.2.2. Advanced Electrophysiology Diagnostic Catheters
14.2.2.3. Ultrasound Electrophysiology Diagnostic Catheters
14.2.3. Electrophysiology Laboratory Devices
14.2.4. Access Devices
14.2.5. Others
14.3. Market Value Forecast, by End-user, 2017–2031
14.3.1. Hospitals
14.3.2. Diagnostic Centers
14.3.3. Clinics
14.3.4. Others
14.4. Market Value Forecast, by Indication, 2017–2031
14.4.1. Atrial Fibrillation (AF)
14.4.2. Atrioventricular Nodal Reentry Tachycardia (AVNRT)
14.4.3. Wolff-Parkinson-White Syndrome (WPW)
14.4.4. Atrial Flutter
14.4.5. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By End-user
14.6.3. By Indication
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2021
15.3. Company Profiles
15.3.1. Abbott Laboratories
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Strategic Overview
15.3.2. Acutus Medical, Inc.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Strategic Overview
15.3.3. F. Siemens AG
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Strategic Overview
15.3.4. Nihon Kohden Corporation
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Strategic Overview
15.3.5. Biosense Webster, Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Strategic Overview
15.3.6. Boston Scientific Corporation
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Strategic Overview
15.3.7. GE Healthcare
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Strategic Overview
15.3.8. Medtronic plc
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Strategic Overview
15.3.9. Koninklijke Philips N.V.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Strategic Overview
15.3.10. Biotronik SE & Co.KG
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Strategic Overview
15.3.11. Microport Scientific Corporation
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Strategic Overview
15.3.12. Other Player

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings